CSIMarket
 
Eiger Biopharmaceuticals Inc   (NASDAQ: EIGR)
 

Eiger Biopharmaceuticals Inc's Customers Performance

EIGR



 
EIGR's Source of Revenues During the corresponding time, Eiger Biopharmaceuticals Inc recorded a revenue increase by 41.06 % year on year, sequentially revenue grew by 18.51 %. While revenue at the Eiger Biopharmaceuticals Inc 's corporate clients

List of EIGR Customers




for the same period Eiger Biopharmaceuticals Inc recorded revenue increase by 41.06 % year on year, sequentially revenue grew by 18.51 %.

List of EIGR Customers

Eiger Biopharmaceuticals Inc's Business Units






Eiger Biopharmaceuticals Inc's Comment on Sales, Marketing and Customers



The company serves customers in the healthcare sector, including federal health care programs such as Medicare, Medicaid, and the Children’s Health Insurance Program. Its healthcare provider clients include U.S.-licensed physicians—such as doctors, dentists, optometrists, podiatrists, and licensed chiropractors—as well as physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, certified nurse midwives, and teaching hospitals. The company also serves private third-party payors and federal and state programs.





Eiger Biopharmaceuticals Inc’s Comment on Sales, Marketing and Customers


The company serves customers in the healthcare sector, including federal health care programs such as Medicare, Medicaid, and the Children’s Health Insurance Program. Its healthcare provider clients include U.S.-licensed physicians—such as doctors, dentists, optometrists, podiatrists, and licensed chiropractors—as well as physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, certified nurse midwives, and teaching hospitals. The company also serves private third-party payors and federal and state programs.








EIGR's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Eiger Biopharmaceuticals Inc 2.55 15.77 -74.96 60
SUBTOTAL 0.00 0.00 0.00 -

Sources: Eiger Biopharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Eiger Biopharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Eiger Biopharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.